Drugs / DDP733
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00215566 | Sep 2005 → ? | irritable bowel syndrome | Dynogen Pharmaceuticals | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00547469 | Oct 2007 → ? | irritable bowel syndrome | Dynogen Pharmaceuticals | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DDP733 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00547469 ↗ |